In a patient with normal iron studies and ferritin, microcytic anemia, elevated red‑cell count and high RDW, what is the most likely diagnosis and the appropriate next step in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Likely Diagnosis: Thalassemia Trait (Beta-Thalassemia Minor)

In a patient with microcytic anemia, elevated red cell count, high RDW, but normal iron studies and ferritin, thalassemia trait is the most likely diagnosis, and the next step is hemoglobin electrophoresis or HPLC to confirm the diagnosis.

Diagnostic Reasoning

The clinical picture strongly suggests thalassemia trait based on several key features:

  • Microcytic anemia with normal iron studies effectively rules out iron deficiency anemia, which would show low ferritin and abnormal iron parameters
  • Elevated red cell count is characteristic of thalassemia trait, where the bone marrow compensates by producing more (albeit smaller) red cells
  • The combination of microcytosis with normal iron stores is the hallmark distinguishing feature of thalassemia from iron deficiency

The RDW Paradox

While high RDW is often cited as favoring iron deficiency over thalassemia, this is an unreliable discriminator in clinical practice. Research shows that 48-71% of thalassemia trait patients actually have elevated RDW 1, 2. The traditional teaching that thalassemia has "normal" RDW while iron deficiency has "high" RDW is oversimplified and frequently incorrect 2.

RDW alone cannot reliably distinguish between these conditions 1, with studies showing only 53.8% specificity and limited diagnostic value even when combined with other indices 3. The key discriminator remains the iron studies, not the RDW.

Next Step in Management

Order hemoglobin electrophoresis or high-performance liquid chromatography (HPLC) to:

  • Confirm elevated HbA2 (>3.5%) characteristic of beta-thalassemia trait
  • Identify other hemoglobinopathies if present
  • Establish definitive diagnosis

Important Caveats

Do not empirically treat with iron supplementation despite the anemia. The guideline evidence 4 demonstrates that:

  • Iron supplementation in patients with genetic microcytic anemias can cause liver iron loading
  • These patients have normal or increased iron stores already
  • Treatment with iron is not only ineffective but potentially harmful

Alternative Considerations

If hemoglobin electrophoresis is normal, consider:

  • Alpha-thalassemia trait (requires genetic testing, as electrophoresis is typically normal)
  • Hereditary sideroblastic anemias (though these typically present with increased ferritin even before transfusions) 4
  • Red cell membrane disorders (though these usually present with different morphology and may have normal MCV) 5

Common Pitfall to Avoid

The most dangerous error is assuming all microcytic anemia is iron deficiency and prescribing iron supplementation without checking iron studies. In this case, you've correctly obtained iron studies first—now act on them by pursuing hemoglobinopathy evaluation rather than empiric iron therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.